Bioxcel Therapeutics Stock Price on November 13, 2024
| BTAI Stock | USD 2.16 0.43 24.86% |
Below is the normalized historical share price chart for BioXcel Therapeutics extending back to March 08, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioXcel Therapeutics stands at 2.16, as last reported on the 1st of March, with the highest price reaching 2.82 and the lowest price hitting 1.82 during the day.
If you're considering investing in BioXcel Stock, it is important to understand the factors that can impact its price. BioXcel Therapeutics secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. BioXcel Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioXcel Therapeutics' Standard Deviation of 10.19, mean deviation of 6.88, and Risk Adjusted Performance of (0.11) to double-check the risk estimate we provide.
As of now, BioXcel Therapeutics' Other Stockholder Equity is increasing as compared to previous years. The BioXcel Therapeutics' current Liabilities And Stockholders Equity is estimated to increase to about 112.8 M, while Total Stockholder Equity is forecasted to increase to (61.7 M). . The current Price To Sales Ratio is estimated to decrease to 1,088. The current Price Earnings Ratio is estimated to decrease to -7.26. BioXcel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of March 2018 | 200 Day MA 12.2761 | 50 Day MA 4.8087 | Beta (0.01) |
BioXcel |
Sharpe Ratio = -0.1293
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BTAI |
Estimated Market Risk
| 10.51 actual daily | 93 93% of assets are less volatile |
Expected Return
| -1.36 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BioXcel Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioXcel Therapeutics by adding BioXcel Therapeutics to a well-diversified portfolio.
Price Book 3.9656 | Enterprise Value Ebitda (0.75) | Price Sales 2.9437 | Shares Float 2 M | Wall Street Target Price 37 |
Related Headline
Acumen Pharmaceuticals Headline on 13th of November 2024
Acumen Pharmaceuticals Inc Q3 2024 Earnings Call Highlights ... by gurufocus.com
Cash and Marketable Securities 259 million as of September 30, 2024.Cash Runway Expected to last into the first half of 2027.RD Expenses 27.2 million in
BioXcel Therapeutics Valuation on November 13, 2024
It is possible to determine the worth of BioXcel Therapeutics on a given historical date. On November 13, 2024 BioXcel was worth 11.04 at the beginning of the trading date compared to the closed value of 9.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BioXcel Therapeutics stock. Still, in general, we apply an absolute valuation method to find BioXcel Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioXcel Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BioXcel Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 10.91 | 11.45 | 10.41 | 10.64 | 47,691 | |
11/13/2024 | 11.04 | 11.04 | 9.48 | 9.90 | 33,783 |
| 10.04 | 10.08 | 8.00 | 8.33 | 46,681 |
| Backtest BioXcel Therapeutics | | | BioXcel Therapeutics History | | | BioXcel Therapeutics Valuation | Previous | Next |
BioXcel Therapeutics Trading Date Momentum on November 13, 2024
| On November 14 2024 BioXcel Therapeutics was traded for 8.33 at the closing time. The top price for the day was 10.08 and the lowest listed price was 8.00 . The trading volume for the day was 46.7 K. The trading history from November 14, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 15.86% . The overall trading delta against the current closing price is 19.19% . |
BioXcel Therapeutics Fundamentals Correlations and Trends
By evaluating BioXcel Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BioXcel Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BioXcel financial account trend analysis is a perfect complement when working with valuation or volatility modules.About BioXcel Therapeutics Stock history
BioXcel Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioXcel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioXcel Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioXcel Therapeutics stock prices may prove useful in developing a viable investing in BioXcel Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 33.5 M | 21.5 M | |
| Net Loss | -149.2 M | -141.7 M |
BioXcel Therapeutics Quarterly Net Working Capital |
|
BioXcel Therapeutics Stock Technical Analysis
BioXcel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
BioXcel Therapeutics Period Price Range
Low | March 1, 2025
| High |
0.00 | 0.00 |
BioXcel Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
BioXcel Therapeutics March 1, 2025 Market Strength
Market strength indicators help investors to evaluate how BioXcel Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioXcel Therapeutics shares will generate the highest return on investment. By undertsting and applying BioXcel Therapeutics stock market strength indicators, traders can identify BioXcel Therapeutics entry and exit signals to maximize returns
BioXcel Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioXcel Therapeutics' price direction in advance. Along with the technical and fundamental analysis of BioXcel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioXcel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.61) | |||
| Total Risk Alpha | (1.33) | |||
| Treynor Ratio | (1.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for BioXcel Stock analysis
When running BioXcel Therapeutics' price analysis, check to measure BioXcel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioXcel Therapeutics is operating at the current time. Most of BioXcel Therapeutics' value examination focuses on studying past and present price action to predict the probability of BioXcel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioXcel Therapeutics' price. Additionally, you may evaluate how the addition of BioXcel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |